Literature DB >> 7715326

p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer.

I B Runnebaum, X W Tong, R König, H Zhao, K Körner, E N Atkinson, R Kreienberg, D G Kieback, H ] Hong Z [corrected to Zhao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7715326     DOI： 10.1016/s0140-6736(95)90745-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Authors:  José Luis Soto Martínez; Carmen M Cabrera Morales; Sabio Serrano Ortega; Miguel Angel López-Nevot
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

2.  Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.

Authors:  Roghayeh Dehghan; Mohammad Ali Hosseinpour Feizi; Nasser Pouladi; Esmaeil Babaei; Vahid Montazeri; Ashraf Fakhrjoo; Ayda Sedaei; Parvin Azarfam; Masoumeh Nemati
Journal:  Pathol Oncol Res       Date:  2014-11-20       Impact factor: 3.201

3.  TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

Authors:  D Mavridou; R Gornall; I G Campbell; D M Eccles
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

4.  Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.

Authors:  Faith Pangilinan; Kerry Geiler; Jessica Dolle; James Troendle; Deborah A Swanson; Anne M Molloy; Marie Sutton; Mary Conley; Peadar N Kirke; John M Scott; James L Mills; Lawrence C Brody
Journal:  Am J Med Genet A       Date:  2008-10-15       Impact factor: 2.802

5.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 6.  Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.

Authors:  J C Semenza; L H Weasel
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

7.  Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.

Authors:  M Esteller; A García; J M Martínez-Palones; J Xercavins; J Reventós
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.

Authors:  I B Runnebaum; T Köhler; E Stickeler; H R Kieback; R Kreienberg
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

9.  Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.

Authors:  S Wang-Gohrke; W Weikel; H Risch; D Vesprini; J Abrahamson; C Lerman; A Godwin; R Moslehi; O Olipade; J S Brunet; E Stickeler; D G Kieback; R Kreienberg; B Weber; S A Narod; I B Runnebaum
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.

Authors:  Chaymaa Marouf; Amal Tazzite; Brehima Diakité; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Tumour Biol       Date:  2014-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.